CompanyGraph
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleRevenue is $1.05B, above the global median of $520.53M
- FinancialsAltman Z-Score 1.35: grey zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
775.42MUSDvs all stocks (USD)
Trailing P/E
37.38xvs Medical Care Facilities peers
Revenue (TTM)
1.05BUSDvs all stocks (USD)
Profit Margin
1.82%vs Medical Care Facilities peers
Beta
1.30xvs all stocks
52-Week Change
-13.33%vs all stocks
Market Capitalization
775.42MUSDvs all stocks (USD)
Enterprise Value
1.14BUSDvs all stocks (USD)
Trailing P/E
37.38xvs Medical Care Facilities peers
PEG Ratio
-0.5072xvs Medical Care Facilities peers
Price to Sales (TTM)
0.5180xvs Medical Care Facilities peers
Price to Book (MRQ)
1.22xvs Medical Care Facilities peers
Enterprise to Revenue
1.09xvs Medical Care Facilities peers
Enterprise to EBITDA
8.86xvs Medical Care Facilities peers
Gross Margin
44.31%vs Medical Care Facilities peers
Profit Margin
1.82%vs Medical Care Facilities peers
Operating Margin
5.37%vs Medical Care Facilities peers
Return on Assets (TTM)
3.20%vs Medical Care Facilities peers
Return on Equity (TTM)
4.19%vs Medical Care Facilities peers
Revenue (TTM)
1.05BUSDvs all stocks (USD)
Revenue per Share (TTM)
5.81USDUpdated Jul 19, 2026Quarterly Revenue Growth
25.20%vs Medical Care Facilities peers
Gross Profit (TTM)
473.32MUSDvs all stocks (USD)
EBITDA (TTM)
178.63MUSDvs all stocks (USD)
Net Income (TTM)
19.11MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
25.20%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
82.27MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-18.44MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Care Facilities peers
Minority Interest (Equity)
175.89MCADFY2025 · Dec 31, 2025Revenue
1.40BCADFY2025 · Dec 31, 2025Cost of Goods Sold
781.34MCADFY2025 · Dec 31, 2025Gross Profit
618.84MCADFY2025 · Dec 31, 2025Operating Income
92.70MCAD66.51M · vs all stocks (USD)
Pre-tax Income
5.31MCADFY2025 · Dec 31, 2025Income Tax Expense
846.00KCADFY2025 · Dec 31, 2025Net Income
4.46MCADFY2025 · Dec 31, 2025EBIT
61.79MCADFY2025 · Dec 31, 2025EBITDA (Income Statement)
178.63MCADFY2025 · Dec 31, 2025Selling, General & Administrative
432.38MCADFY2025 · Dec 31, 2025Non-operating Interest Income
1.72MCADFY2025 · Dec 31, 2025Non-operating Interest Expense
56.48MCADFY2025 · Dec 31, 2025EPS (Basic)
-0.0300CADFY2025 · Dec 31, 2025EPS (Diluted)
-0.0300CADFY2025 · Dec 31, 2025Basic Shares Outstanding
252.80MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
252.80MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
4.46MCADFY2025 · Dec 31, 2025Minority Interests (P&L)
-11.82MCADFY2025 · Dec 31, 2025Operating Cash Flow
135.24MCADFY2025 · Dec 31, 2025Free Cash Flow
107.37MCADFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
133.75MCADFY2025 · Dec 31, 2025Income Tax Paid
16.62MCADFY2025 · Dec 31, 2025Interest Paid
30.88MCADFY2025 · Dec 31, 2025Starting Profit (CF Statement)
4.46MCADFY2025 · Dec 31, 2025Depreciation & Amortization
93.76MCADFY2025 · Dec 31, 2025Deferred Taxes (CF)
-16.38MCADFY2025 · Dec 31, 2025Stock-based Compensation
22.69MCADFY2025 · Dec 31, 2025Other Non-cash Items
32.52MCADFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
47.30MCADFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-49.12MCADFY2025 · Dec 31, 2025Capital Expenditures
-27.87MCADFY2025 · Dec 31, 2025Net Acquisitions
-58.61MCADFY2025 · Dec 31, 2025Other Investing Activity
-4.47MCADFY2025 · Dec 31, 2025Net Investing Cash Flow
-90.95MCADFY2025 · Dec 31, 2025Long-term Debt Issuance
148.34MCADFY2025 · Dec 31, 2025Long-term Debt Payments
-74.72MCADFY2025 · Dec 31, 2025Common Stock Repurchase
-1.83MCADFY2025 · Dec 31, 2025Common Dividends Paid
0.00CADFY2025 · Dec 31, 2025Other Financing Charges
-150.41MCADFY2025 · Dec 31, 2025Net Financing Cash Flow
-20.29MCADFY2025 · Dec 31, 2025Shares Outstanding
255.51MSharesUpdated Jul 19, 2026Float Shares
234.12MSharesUpdated Jul 19, 2026% Held by Insiders
21.07%vs all stocks
% Held by Institutions
3.53%vs all stocks
Total Cash (MRQ)
95.44MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.5250USDUpdated Jul 19, 2026Total Debt (MRQ)
564.48MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.7568xvs Medical Care Facilities peers
Current Ratio (MRQ)
0.8270xvs Medical Care Facilities peers
Book Value per Share (MRQ)
2.45USDUpdated Jul 19, 2026Total Assets
2.10BCAD1.50B · vs all stocks (USD)
Total Current Assets
369.61MCADFY2025 · Dec 31, 2025Total Liabilities
1.06BCADFY2025 · Dec 31, 2025Total Non-current Assets
1.73BCADFY2025 · Dec 31, 2025Total Non-current Liabilities
700.02MCADFY2025 · Dec 31, 2025Total Current Liabilities
357.47MCADFY2025 · Dec 31, 2025Cash
133.75MCADFY2025 · Dec 31, 2025Cash & Cash Equivalents
133.75MCADFY2025 · Dec 31, 2025Accounts Receivable
170.94MCADFY2025 · Dec 31, 2025Inventory
2.46MCADFY2025 · Dec 31, 2025Accounts Payable
91.60MCADFY2025 · Dec 31, 2025Short-term Debt
112.74MCADFY2025 · Dec 31, 2025Deferred Revenue
80.58MCADFY2025 · Dec 31, 2025Other Current Liabilities
9.81MCADFY2025 · Dec 31, 2025Long-term Debt
487.91MCADFY2025 · Dec 31, 2025Other Non-current Liabilities
24.91MCADFY2025 · Dec 31, 2025Common Stock (Book)
808.06MCADFY2025 · Dec 31, 2025Retained Earnings
-38.34MCADFY2025 · Dec 31, 2025Total Shareholders' Equity
1.04BCAD745.67M · vs all stocks (USD)
52-Week Low
2.44USDUpdated Jul 19, 202652-Week High
4.31USDUpdated Jul 19, 202652-Week Change
-13.33%vs all stocks
Beta
1.30xvs all stocks
50-Day MA
3.09USDUpdated Jul 19, 2026200-Day MA
3.08USDUpdated Jul 19, 2026Avg 10-Day Volume
26.13KSharesUpdated Jul 19, 2026Avg 30-Day Volume
47.84KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
0.0800USDUpdated Jul 19, 2026Other Income / Expense
-30.25MCADFY2025 · Dec 31, 20252 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
Drawdown With OCF Coverage And Growth Consistency
Well below its peak, with cash covering profit and growth that has been steady.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.44Profit Margin: 0.02
Financial Health
Altman Z-Score 1.35: grey zoneSignificant
Altman Z-Score: 1.35
High earnings qualityNotable
Earnings Quality Score: 1.68
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Revenue is $1.05B, above the global median of $520.53MNotable
Revenue (USD): 1,050,072,294Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Ningxia Zhongke Biotechnology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Shandong Link Science And Technology Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Aimer Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionInterfaceFlow
Shandong Senter Electronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shandong Fengyuan Chemical Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Yonggui Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Jinjia Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shikoku Kasei Holdings Corporation
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Middle East Healthcare Company
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Jiangsu Canlon Building Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
JSL S.A.
2 interpretationsDrawdown With OCF Coverage And Growth ConsistencyDrawdown With FCF And Cash Backing
eToro Group Ltd.
2 interpretationsDrawdown With OCF Coverage And Growth ConsistencyDrawdown With FCF And Cash Backing
Primoris Services Corporation
2 interpretationsDrawdown With OCF Coverage And Growth ConsistencyDrawdown With FCF And Cash Backing